Jens Overgaard

46PUBLICATIONS
104CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyInstruments and techniquesEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Sep 16, 2026
Pattern of Failure in Nasopharyngeal Carcinoma After Radiotherapy in a Low-Incidence Population: A DAHANCA Study.

|Jul 23, 2026
Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1.

|Sep 19, 2025
Late dysphagia after changes in high-dose clinical tumour volume margin for head and neck cancer patients.

Ruta Zukauskaite, Jesper Grau Eriksen, Jørgen Johansen

|Sep 11, 2025
Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses.

Christian Rønn Hansen, Anders S Bertelsen, Irene Hazell

|Aug 30, 2025
Dual-tracer autoradiographic analysis of glucose metabolism and hypoxia in orthotopic and PDX tumor models.

Morten Busk, Martin K Thomsen, Jens Overgaard

|Aug 27, 2025
Mutational profile of oropharyngeal squamous cell carcinoma in relation to HPV, tobacco smoking and prognosis with validation in the DAHANCA 19 randomized trial.

Jacob Lilja-Fischer, Morten Horsholt Kristensen, Pernille Lassen

Pageof 8

Frequent Collaborators

11 joint publications

Jørgen Johansen

11 joint publications

Jesper Grau Eriksen

8 joint publications

Jan Alsner

6 joint publications

Jeppe Friborg